Articles > Reference > Dictionaries, Thesauruses, Pictures, and Press Releases > M2 Presswire press releases > January-March 2009 > Wednesday, February 25

Article: ITRO, OPTR, ELST.

Article from:
M2 Presswire
Article date:
February 25, 2009
Copyright

M2 PRESSWIRE-25 February 2009-StockProfiler.US: ITRO, OPTR, ELST(C)1994-2009 M2 COMMUNICATIONS LTD

RDATE:25022009

New York, NY -- Itronics Inc. (OTCBB: ITRO) (FRANKFURT: ITG) (BERLIN: ITG); Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR); Electronic Systems Technology, Inc. (OTCBB: ELST)

Stock Profiler welcomes investors to sign up at www.stockprofiler.us. to subscribe to our newsletter.

Stock Profiler is pleased to introduce Lifespan Inc. (PINKSHEETS: LSPN) to the investment community. As of 2/23/2009, Barchart.com has an 80% Buy Rating on Lifespan Inc. (PINKSHEETS: LSPN). Click here to see the chart: ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: Available Now - Optimer Pharmaceuticals Inc: ...
M2 Presswire;  September 1, 2008 ;     700+ words ... ... and Markets: Available Now - Optimer Pharmaceuticals Inc: Premium Company Profile ... announced the addition of the "Optimer Pharmaceuticals Inc: Premium Company Profile ... Disclaimer LIST OF FIGURES: Figure 1: Optimer Pharmaceuticals- Operating Revenue/Cost Analysis ...

Article: Research and Markets: Available Now - Optimer ...
Business Wire;  September 1, 2008 ;     700+ words ... ... addition of the "Optimer Pharmaceuticals Inc: Premium Company ... FIGURES: Figure 1: Optimer Pharmaceuticals- Operating Revenue ... 10 Figure 2: Optimer Pharmaceuticals- Key Strategic ...

Article: Optimer Pharmaceuticals to Present at September ...
PR Newswire;  September 3, 2009 ;     654 words ... ... 3 /PRNewswire-FirstCall/ -- Optimer Pharmaceuticals, Inc. today announced that the Company ... days following the meeting. About Optimer Pharmaceuticals Optimer Pharmaceuticals, Inc. is a biopharmaceutical company ...

Article: Optimer Pharmaceuticals Receives Production Patent ...
PR Newswire;  April 13, 2009 ;     700+ words ... ... 13 /PRNewswire-FirstCall/ -- Optimer Pharmaceuticals, Inc. announced today that the United ... probability of CDI recurrence. About Optimer Pharmaceuticals Optimer Pharmaceuticals, Inc. is a biopharmaceutical company ...

Article: Optimer Pharmaceuticals Announces Presentations of ...
PR Newswire;  September 2, 2009 ;     700+ words ... ... Results from studies related to Optimer Pharmaceuticals, Inc.'s lead developmental product ... number: D-1433 in Hall B About Optimer Pharmaceuticals Optimer Pharmaceuticals, Inc. is a biopharmaceutical company ...

Article: Optimer Pharmaceuticals to Present at the Canaccord ...
PR Newswire;  August 4, 2009 ;     558 words ... ... 4 /PRNewswire-FirstCall/ -- Optimer Pharmaceuticals, Inc. is scheduled to present at ... days following the meeting. About Optimer Pharmaceuticals Optimer Pharmaceuticals, Inc. is a biopharmaceutical company ...

Article: Optimer Pharmaceuticals to Present at June 2009 ...
PR Newswire;  June 4, 2009 ;     598 words ... ... June 4 /PRNewswire-FirstCall/ -- Optimer Pharmaceuticals, Inc. today announced that the Company ... days following the meeting. About Optimer Pharmaceuticals Optimer Pharmaceuticals, Inc. is a biopharmaceutical company ...

Article: Optimer Pharmaceuticals to Present at the Cowen and ...
Biotech Week;  March 25, 2009 ;     700+ words ...Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR ... Eastern Time (see also Optimer Pharmaceuticals, Inc.). A live audio ... following the meeting. About Optimer Pharmaceuticals Optimer Pharmaceuticals ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives